Implications of liver fibrosis in clinical trials
| dc.coverage | DOI: 10.1016/j.aohep.2025.102112 | |
| dc.creator | Jahagirdar, Vinay | |
| dc.creator | Rama, Kaanthi | |
| dc.creator | Cabrera, Daniel | |
| dc.creator | Idalsoaga, Francisco | |
| dc.creator | Díaz, Luis Antonio | |
| dc.creator | Arrese, Marco | |
| dc.creator | Arab, Juan Pablo | |
| dc.date | 2025 | |
| dc.date.accessioned | 2026-01-05T21:09:44Z | |
| dc.date.available | 2026-01-05T21:09:44Z | |
| dc.identifier | https://investigadores.uandes.cl/en/publications/b19bbf91-5cb7-41f6-853a-bc356eeba7f4 | |
| dc.identifier.uri | https://repositorio.uandes.cl/handle/uandes/63997 | |
| dc.language | eng | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.source | vol.30 (2025) nr.2 p.102112 | |
| dc.title | Implications of liver fibrosis in clinical trials | eng |
| dc.type | Editorial | eng |
| dc.type | Editorial | spa |